Introduction In the past years, three monoclonal antibodies have been approved in Germany for the treatment of the severe form of CRSwNP. This study investigated the effectiveness and safety of dupilumab, omalizumab and mepolizumab in clinical use.
No takes yet. Share an insight, caveat, or question.
Gunder et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: